The National Cancer Institute Multi-Screening Trial.
Prorok
P
P
Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Maryland, USA.
D000368:Aged; D018394:CA-125 Antigen / Q000097:blood; D015179:Colorectal Neoplasms / Q000517:prevention & control*; D003365:Costs and Cost Analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007258:Informed Consent; D008175:Lung Neoplasms / Q000517:prevention & control*; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009316:National Institutes of Health (U.S.); D010051:Ovarian Neoplasms / Q000517:prevention & control*; D010865:Pilot Projects; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014481:United States
D018394:CA-125 Antigen; D017430:Prostate-Specific Antigen